(R)-N-(1-(2,4-Dichlorophenyl)-2-(1H-imidazol-1-yl)ethyl)-4-(5-(3-morpholinophenyl)-1,3,4-oxadiazol-2-yl)benzamide

ID: ALA4126409

Chembl Id: CHEMBL4126409

PubChem CID: 145961897

Max Phase: Preclinical

Molecular Formula: C30H26Cl2N6O3

Molecular Weight: 589.48

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(N[C@@H](Cn1ccnc1)c1ccc(Cl)cc1Cl)c1ccc(-c2nnc(-c3cccc(N4CCOCC4)c3)o2)cc1

Standard InChI:  InChI=1S/C30H26Cl2N6O3/c31-23-8-9-25(26(32)17-23)27(18-37-11-10-33-19-37)34-28(39)20-4-6-21(7-5-20)29-35-36-30(41-29)22-2-1-3-24(16-22)38-12-14-40-15-13-38/h1-11,16-17,19,27H,12-15,18H2,(H,34,39)/t27-/m0/s1

Standard InChI Key:  FNIIQAGFZKIRME-MHZLTWQESA-N

Alternative Forms

  1. Parent:

    ALA4126409

    ---

Associated Targets(non-human)

ERG11 Cytochrome P450 51 (617 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Lanosterol 14-alpha demethylase (57 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 589.48Molecular Weight (Monoisotopic): 588.1443AlogP: 5.91#Rotatable Bonds: 8
Polar Surface Area: 98.31Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 6.78CX LogP: 4.87CX LogD: 4.80
Aromatic Rings: 5Heavy Atoms: 41QED Weighted: 0.24Np Likeness Score: -1.63

References

1. Friggeri L, Hargrove TY, Wawrzak Z, Blobaum AL, Rachakonda G, Lindsley CW, Villalta F, Nes WD, Botta M, Guengerich FP, Lepesheva GI..  (2018)  Sterol 14α-Demethylase Structure-Based Design of VNI (( R)- N-(1-(2,4-Dichlorophenyl)-2-(1 H-imidazol-1-yl)ethyl)-4-(5-phenyl-1,3,4-oxadiazol-2-yl)benzamide)) Derivatives To Target Fungal Infections: Synthesis, Biological Evaluation, and Crystallographic Analysis.,  61  (13): [PMID:29894182] [10.1021/acs.jmedchem.8b00641]
2. Friggeri L, Hargrove TY, Wawrzak Z, Guengerich FP, Lepesheva GI..  (2019)  Validation of Human Sterol 14α-Demethylase (CYP51) Druggability: Structure-Guided Design, Synthesis, and Evaluation of Stoichiometric, Functionally Irreversible Inhibitors.,  62  (22): [PMID:31663733] [10.1021/acs.jmedchem.9b01485]

Source